NeuroNexus has engineered neural-interface technology for more than twenty years — and run our own funded research at the frontier the whole time, with partners like Harvard, Mayo Clinic, Purdue, and Philips. The field has published 5,000+ studies on our probes. We make the tools because we use them: the people who capture the signal know best how to read it.
More than twenty years pioneering neural-interface technology, from organoids to patients.
Peer-reviewed studies that cite NeuroNexus technology — across species, systems, and timescales.
Active labs run NeuroNexus probes, instruments, and software worldwide.
NeuroNexus runs its own funded research at the edge of electrophysiology — not as marketing, but as method. We build probes, instruments, and software by using them on the hardest problems ourselves, which is why the guidance stays ahead of the field and the tools are shaped by the people who record with them. We are a working research organization, not a vendor with a lab attached. The people who capture the signal know best how to read it.
Recording from brain organoids with a Harvard biology lab — among the hardest signals to capture, run end to end on Radiens.
Translational neuro-monitoring work with Mayo Clinic, from the bench toward the operating room.
Advancing neural-interface design and fabrication with Purdue.
A neuromodulation program with Philips Research.
The Buzsáki Group (NYU) records hippocampal circuits in rats and mice on 256-channel arrays — 63 publications on NeuroNexus probes.
Headley & Paré (Rutgers) built a custom 4-shank probe to span the basolateral amygdala in chronic rat. (Neuron, 2018)
Wang, Kral & Land (Hannover Medical School) localized ABR sources with topographic multichannel EEG. (J. Neurosci., 2025)
The Ardell Group (UCLA) used epicardial grids to modulate cardiac rhythm in large-animal studies. (2022–2023)
Our own NIH-funded organoid project — with a Harvard biology lab, PI Daryl R. Kipke, NeuroNexus's founder and CEO — runs end to end on Radiens: acquisition, analysis, and quality, on the same software we ship. It is also the work behind the organoid platform on our roadmap, so the proof and the direction are the same project. When we say Radiens is built by people who do the science, this is what we mean.
Yes. NeuroNexus runs its own NIH-funded research programs at the frontier of electrophysiology — peer-level collaborations spanning organoid recording (with a Harvard lab), clinical intraoperative neuro-monitoring (Mayo Clinic), next-generation probes (Purdue), and deep brain stimulation (Philips Research). We build neural-interface tools by using them on hard problems ourselves.
More than 5,000 peer-reviewed publications cite NeuroNexus technology, across species and systems — from high-density hippocampal recording in the Buzsáki Group at NYU, to custom amygdala probes at Rutgers, to auditory-brainstem source localization at Hannover Medical School, to cardiac neuromodulation at UCLA. The technology has been proven by the field for more than two decades.
Because the guidance and the tools stay ahead of the field. NeuroNexus is a working research organization, not a vendor with a lab attached: we run funded programs at the edge, so our application scientists advise from current practice and our probes, instruments, and software are shaped by the people who record with them. As we put it: the people who capture the signal know best how to read it.
Yes. Our NIH-funded brain-organoid project runs end to end on Radiens — acquisition, analysis, and quality — the same software we ship to other labs. It is also the work behind the organoid platform on our roadmap. Radiens is dogfooded on our own frontier science before it reaches you.
NeuroNexus application scientists help equip a study — probes and protocols tuned to the preparation, custom geometries made to spec, and the full platform from probe to Radiens under one accountable partner. The fastest start is to talk to a scientist about your recording and your goals.